The opinion of the court was delivered by: Thomas M. Digirolamo United States Magistrate Judge
MEMORANDUM OPINION GRANTING PLAINTIFF'S ALTERNATIVE MOTION FOR REMAND
John Harrison DeRohn, Jr. ("Plaintiff" or "Claimant") brought this action under 42 U.S.C. § 405(g) for judicial review of the final decision of the Commissioner of the Social Security Administration ("Commissioner"), denying his claims for Disability Insurance Benefits ("DIB") and Supplemental Security Income ("SSI") under Titles II and XVI of the Social Security Act, 42 U.S.C.§§ 401-433, 1381-83(c). Before the Court are Plaintiff's Motion for Summary Judgment (Pl.'s Mot. Summ., ECF No. 14) and Defendant's Motion for Summary Judgment. (Def.'s Mot. Summ., ECF No. 18). No hearing is deemed necessary. Local Rule 105.6 (D. Md.). For the reasons presented below, Plaintiff's Alternative Motion for Remand is GRANTED.
Plaintiff filed his applications on February 27, 2009 alleging disability since August 13, 2006 due to disc and neck injuries and depression. R. at 124, 128, 145. His claims were denied initially and on reconsideration. R. at 58, 62, 70, 72. On May 16, 2011, a hearing was held before an administrative law judge ("ALJ") at which Plaintiff and a vocational expert ("VE") testified. R. at 25-51. Plaintiff was represented by counsel. In a decision May 25, 2011, the ALJ denied Plaintiff's request for benefits. R. at 13-24. The Appeals Council denied Plaintiff's request for review rendering the ALJ's decision the final decision subject to judicial review. R. at 1-3.
The ALJ evaluated Plaintiff's claims for DIB and SSI using the sequential processes set forth in 20 C.F.R. § 404.1520, 416.920. At the first step, the ALJ determined that Claimant had not engaged in substantial gainful activity since his alleged onset date. At step two, the ALJ determined that Claimant suffered from the following severe impairments: degenerative disc disease, depression, anxiety and history of substance abuse disorder. At step three, the ALJ found that his impairments did not meet or equal the Listings of Impairments set forth in 20 C.F.R. pt. 404, subpt, P, app. 1. The ALJ concluded at step four that, given his Residual Functional Capacity ("RFC") Plaintiff was incapable of performing his past relevant work. At step five, the ALJ concluded that Claimant was capable of performing jobs that existed in significant numbers in the national economy. Accordingly, he concluded that Claimant was not disabled. R. at 13-24.
The role of this court on review is to determine whether substantial evidence supports the Commissioner's decision and whether the Commissioner applied the correct legal standards.
42 U.S.C. § 405(g)(1994 & Supp. V 1999); Pass v. Chater, 65 F.3d 1200, 1202 (4th Cir. 1995); Hays v. Sullivan, 907 F.2d 1453, 1456 (4th Cir. 1990). Substantial evidence is "such relevant evidence as a reasonable mind might accept as adequate to support a conclusion." Richardson v. Perales, 402 U.S. 389, 401 (1971) (quoting Consolidated Edison Co. v. NLRB, 305 U.S. 197, 229 (1938)). It is more than a scintilla, but less than a preponderance, of the evidence presented. Shively v. Heckler, 739 F.2d 987, 989 (4th Cir. 1984). It is such evidence that a reasonable mind might accept to support a conclusion, and must be sufficient to justify a refusal to direct a verdict if the case were before a jury. Hays, 907 F.2d at 1456 (quoting Laws v. Celebrezze, 368 F.2d 640, 642 (4th Cir. 1966)). This court cannot try the case de novo or resolve evidentiary conflicts, but rather must affirm a decision supported by substantial evidence. Id.
Plaintiff argues that the ALJ erred in his finding that Plaintiff's Immune Thrombocytopenic Purpura ("ITP") was not a severe impairment at step two of the sequential evaluation. Specifically, he argues that the ALJ erred in finding that Plaintiff's ITP did not constitute a severe impairment because it "has not lasted for a period of at least twelve months as it was diagnosed in November, 2010;*fn1 therefore, this impairment has not met the durational requirement of SSR 82-52." R. at 15.
The Court agrees with Plaintiff (and the Commissioner, see Def.'s Mot. Summ., ECF No. 18 at 9) that the ALJ erred by imposing a durational standard at step two of the sequential evaluation in determining whether Plaintiff's impairment was severe. Plaintiff's burden of showing a severe impairment at step two is not grounded in any durational requirement.*fn2 As recently stated by this Court in Taylor v. Astrue, 2012 WL 294532 (D. Md. Jan. 31, 2012), "Plaintiff's burden of showing a severe impairment at step two is only a 'de minimis screening device used to dispose of groundless claims.' Webb v. Barnhart, 433 F.3d 683, 687 (9th Cir.2005) (internal brackets and quotation marks omitted). An ALJ may only declare an impairment to be "not severe" if the medical evidence on record clearly establishes that the impairment is "a slight abnormality that has no more than a minimal effect on an individual's ability to work." Id. (internal quotation marks and citation omitted). Furthermore, any doubt or ambiguity in the evidence at step two should be resolved in the claimant's favor and the ALJ should continue with the sequential evaluation." See SSR 85--28.
Here, while the ALJ found Plaintiff's ITP not severe, he made no finding with respect to its effect of Plaintiff's ability to do work; and therefore the Court has no basis to discern support for his finding. At a minimum, the Court notes that Plaintiff was admitted to the hospital for four days after the original diagnosis of ITP. R. at 461, 484-88. He was treated with intravenous Decadron therapy and WinRo. R. at 461. Subsequent to treatment, Plaintiff complained of fatigue and shortness of breath with exertion. Plaintiff was again admitted to the hospital on December 18, 2010 and was again given another platelet transfusion and WinRo. R. at 477-80. He was again admitted on December 30, 2010 when his platelet count dropped from 150,000 to 11,000. R. at 469. Plaintiff testified at the hearing that he thought he had undergone 14 blood transfusions. R. at 33; see also R. at 461-96, 588-96. He testified that having ITP felt like having the flu all the time with no energy and cold sweats. R. at 34. At the time of the hearing, Plaintiff was taking weekly IVs of Rituxab/Rituximab for three hour sessions. R. at 33-35, 461-81.
The Commissioner urges the Court to find this error harmless because the ALJ found other impairments to be severe and proceeded to the remaining steps in the sequential evaluation and that the ALJ's RFC ...